A little research goes a long way, if you’re asking one man who recently filed a GranuFlo lawsuit alleging a connection between the dialysis drug and his mother’s untimely death after learning online of its association with life-threatening heart injuries.

According to a recent report, the plaintiff in this case says he started to wonder if his mother suffered complications from the medication after an internet search revealed more than 450 dialysis lawsuits citing sudden cardiac death, strokes and other heart injuries.  He also found that the hospital at which she received her dialysis treatment had a history of administering GranuFlo.

“My family and I can’t help but wonder if her death was caused by the dosage of GranuFlo she received during dialysis,” the plaintiff now says.

GranuFlo Recall Suits Now Pending in Massachusetts Federal Court

These cases are now pending in a federal multidistrict litigation now underway in the U.S. District Court, District of Massachusetts after being filed by individuals who were allegedly affected by a dialysis recall issued almost two years ago by the U.S. Food and Drug Administration (FDA). As per an announcement on June 25, 2012, the federal agency found GranuFlo and NaturaLyte’s alleged side effects to be serious and potentially fatal.

Plaintiffs in NaturaLyte and GranuFlo lawsuits blame their manufacturer, Fresenius Medical Care for injuries they allegedly sustained, which could have been avoided if the general public had been adequately warned about its products’ side effects.

Prior to the GranuFlo recall, Fresenius issued an Urgent Product Notification on March 2012 that warned of their association with strokes, cardiovascular arrest and other injuries. Lawsuits allege that this notification was issued too late, however, and the company had prior knowledge of fatalities that occurred after use of the medications.

According to a New York Times report issued that June, the FDA found an internal memo from November 2011 that acknowledged 941 patient deaths that may have stemmed from GranuFlo and NaturaLyte usage. At the time, only physicians leading dialysis treatments in facilities owned by Fresenius were warned of this connection, and were told to adjust dosages of the medication. The FDA has reportedly begun to investigate whether the company violated federal regulations by withholding this information from the public.

Were You Affected by the GranuFlo Recall? Call Us Today.

If you or a loved one sustained the serious side effects associated with the 2012 GranuFlo recall, call us today to file a claim at (877) 779-1414.

Published February 11, 2014 by